Bone Health Assessment in Men on Androgen Deprivation Therapy for Prostate Cancer: A Nurse Practitioner-Led Quality Improvement Protocol


Identification: unj_nd19_02
Issue: November-December 2019
Volume: Volume 39 Number 6
Credits (Post Test and/or Evaluation Required)
Available until 12/31/2021
  • 1.30 - CH


Description

Contact hours available until 12/31/2021.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation.

Faculty, Planners and Authors Conflict of Interest Disclosure:
The author(s), editor, editorial board, content reviewers, and education director reported no actual or potential conflict of interest in relation to this continuing nursing education article.

Commercial Support and Sponsorship:

No commercial support or sponsorship declared.

Accreditation Statement:
This educational activity is provided by the Society of Urologic Nurses and Associates (SUNA).

The Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

SUNA is a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556.

This article was reviewed and formatted for contact hour credit by Michele Boyd, MSN, RN-BC, SUNA Education Director.

Learning Outcome:
After completing this learning activity, the learner will be able to discuss how a Nurse Practitioner-led QI protocol facilitated consistency in providing evidence-based practice related to bone health screening, education and treatment for men with prostate cancer on ADT.

Learner Engagement Activity:
This article emphasizes the increased risk for fracture in men who are being treated with ADT for prostate cancer. Visit the NCCN website at https://www.nccn.org/professio... to review the guidelines for prostate cancer.

Author(s):

Credits Available


Expired On: Dec 31, 2021

You must be logged in and own this product in order to post comments.

Louise Kester
9/10/20 2:00 pm

I read this article. Found the information relevant to our practice. As a staff nurse I given a fair amount of ADT injections to our prostate cancer patient. Spoke with one of our lead MD's who does a lot of CA Tx. We discussed bone loss and treatment, he asked me to encourage the pt's to use calcium and vitamin D as the providers recommend. This is a real issue with this treatment mostly in the older population that is a bone loss, fall rise group.